Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.27
+0.25 (4.15%)
Nov 5, 2026, 11:02 AM EST - Market open

Myriad Genetics Revenue

Myriad Genetics had revenue of $202.70M in the quarter ending September 30, 2026, a decrease of -1.46%. This brings the company's total for the last twelve months to $803.60M, down -2.63% year-over-year. In the year 2025, Myriad Genetics had annual revenue of $824.50M, down -1.56%. That makes Myriad Genetics the 8,682nd largest company in the world by revenue and 1,941st in the United States.

Revenue (ttm)
$803.60M
Revenue Growth
-2.63%
P/S Ratio
0.72
Revenue / Employee
$297,630
Employees
2,700
Market Cap
599.72M

Revenue Chart

Revenue by Geography

  • United States 768.00M 93.1%
  • Rest of world 56.50M 6.9%
Fiscal year ended Dec 31, 2025 See the full Myriad Genetics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025824.50M-13.10M-1.56%
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M52.00M8.14%
Jun 30, 2020638.60M-212.50M-24.97%
Jun 30, 2019851.10M107.40M14.44%
Jun 30, 2018743.70M15.00M2.06%
Jun 30, 2017728.70M-11.80M-1.59%
Jun 30, 2016740.50M17.40M2.41%
Jun 30, 2015723.10M-55.10M-7.08%
Jun 30, 2014778.20M165.00M26.91%
Jun 30, 2013613.20M117.20M23.63%
Jun 30, 2012496.01M93.92M23.36%
Jun 30, 2011402.08M39.44M10.87%
Jun 30, 2010362.65M36.12M11.06%
Jun 30, 2009326.53M103.67M46.52%
Jun 30, 2008222.86M77.57M53.39%
Jun 30, 2007145.29M31.01M27.13%
Jun 30, 2006114.28M31.87M38.68%
Jun 30, 200582.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
NeoGenomics787.75M
OPKO Health654.10M
GeneDx Holdings454.43M
Castle Biosciences357.28M
Fulgent Genetics323.93M
Biodesix102.94M
Burning Rock Biotech73.70M
Exagen71.12M
Revenue Rankings